Liver Cancer Expert Witnesses in North Carolina

This highly qualified expert has extensive experience in the fields of cancer, biomedical research, pre-clinical animal research and ethics, and drug development, among others. After earning his BS from East Carolina University and his MS from The University of North Carolina at Greensboro, this expert completed his PhD in genetics and molecular biology at The University of North Carolina, Chapel Hill. He also went on to complete his MBA in biosciences management at North Carolina State University. This expert is an active member of the American Association of Immunologists, the Society for Leukocyte Biology, and the American Association for Cancer Research. In addition to being extensively published, he is the current associate editor of Frontiers in Immunology and Frontiers in Microbiology. Further, this expert has been engaged in a variety of university program development and research operations leadership roles throughout his career. Among his former roles, he has served as a research analyst with the Center for Human Genetics at Duke University Medical Center, a research associate for microbiology and immunology at The University of North Carolina Chapel Hill, and as an assistant professor of inflammatory diseases at Virginia-Maryland College of Veterinary Medicine. This expert currently maintains two assistant professorships at a public medical school in Virginia, in addition to his primary role as an associate professor of inflammatory diseases at a veterinary medicine education school.

This highly qualified, triple board certified doctor completed his medical school at the American University of Beirut (AUB). He subsequently joined the internal medicine residency program at Wayne State University. After completion of the residency, he joined the hematology oncology fellowship program at the Karmanos Cancer Institute, also at Wayne State University. He then joined faculty as an Assistant Professor in the area of GI oncology. During this time, he was involved in translational research focused on pancreatic cancer. Immediately following his time at Wayne state, this doctor moved to his current position at a GA university as the director of the GI Oncology program . He is designated as a Distinguished Cancer Scholar by the Georgia Cancer Coalition. He is also currently the medical director of the Clinical Trials Office, where his mission relies on translational projects related to gastrointestinal malignancies, specifically pancreatic and colorectal cancer, to bring observations derived from invitro models of cancer cell growth to the clinic. He has over 150 peer reviewed publications, and is the lead clinical investigator on at least eight trials focused on the evaluation of novel treatments in patients with early stage or advanced cancer.